Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Depreciation & Amortization (CF): 2016-2021

Historic Depreciation & Amortization (CF) for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Jun 2021 value amounting to $317,000.

  • Rhythm Pharmaceuticals' Depreciation & Amortization (CF) was N/A to $317,000 in Q2 2021 from the same period last year, while for Jun 2021 it was $679,000, marking a year-over-year change of. This contributed to the annual value of $690,000 for FY2020, which is 17.27% down from last year.
  • As of Q2 2021, Rhythm Pharmaceuticals' Depreciation & Amortization (CF) stood at $317,000, which was up 57.71% from $201,000 recorded in Q1 2021.
  • In the past 5 years, Rhythm Pharmaceuticals' Depreciation & Amortization (CF) ranged from a high of $317,000 in Q2 2021 and a low of -$6,000 during Q3 2020.
  • Over the past 3 years, Rhythm Pharmaceuticals' median Depreciation & Amortization (CF) value was $196,000 (recorded in 2019), while the average stood at $189,125.
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Depreciation & Amortization (CF) soared by 301.64% in 2019, and later tumbled by 103.14% in 2020.
  • Quarterly analysis of 5 years shows Rhythm Pharmaceuticals' Depreciation & Amortization (CF) stood at $60,000 in 2017, then skyrocketed by 256.67% to $214,000 in 2018, then decreased by 10.75% to $191,000 in 2019, then slumped by 103.14% to -$6,000 in 2020, then rose by 20.36% to $317,000 in 2021.
  • Its Depreciation & Amortization (CF) was $317,000 in Q2 2021, compared to $201,000 in Q1 2021 and -$6,000 in Q3 2020.